European Archives - Page 268 of 1179 - European Medical Journal

Understanding Bronchiectasis Pathogenesis and Exacerbation

The chronic and progressive inflammatory disease bronchiectasis is characterised by permanent bronchi dilation and by symptoms such as…

Precision Strikes: Personalising Stage IIIA Lung Cancer Treatment with Targeted and Immune Therapies

The treatment landscape for potentially surgically resectable Stage IIIA non-small cell lung cancer (NSCLC), particularly for…

Advancing Respiratory Care: The Role of Simulation in Clinical Education

The demand for highly skilled respiratory clinicians grows as respiratory care becomes increasingly complex with rapid advancement…

Pleural Metastasis of Papillary Thyroid Cancer: Clinical Implications

Papillary thyroid cancer (PTC) is the most common form of thyroid cancer, accounting for 80–85% of thyroid cancer cases…

Gold crown on blue background

HCPs rank pharma in top sectors for trust, says Ipsos

Healthcare professionals’ trust in the pharmaceutical industry has risen since 2020, with many doctors and nurses now expressing high trust.

Key Predictors of Testosterone Recovery After Prostate Cancer Treatment

A study has provided new insights into testosterone recovery following androgen deprivation therapy in men undergoing radiotherapy for prostate cancer.

Impact of Airway Microbiome on Asthma Inflammation

New research reveals the significance of the airway microbiome in severe asthma, especially in ‘type-2 low’ neutrophilic asthma.

Genetic Mutations Linked to Early Menopause

Four genes with significant effects on the timing of menopause have been uncovered by a recent study offering insights into reproductive aging and cancer risks

The Effect of Exposure to Radiofrequency Fields on Cancer Risk

A review found no strong evidence linking radiofrequency electromagnetic fields from mobile phones and other sources to an increased risk of cancer, including brain tumours.

Prolonged Anticoagulation After COVID-19 Reduces Risk of Blood Clots: ERS 2024

Findings from ERS 2024 show that continuing anticoagulation after the acute phase of COVID-19 significantly reduces the risk of venous thromboembolism in recovering patients.